Specifically, anti-CD40 Ab administration induced the differentiation of T2 and MZ B cells and expanded the population of IL-10+ Bregs in vitro and in vivo, resulting in significantly improved renal disease and controlled progression of lupus in mice (73). Here, IL10 is linked to systemic lupus erythematosus.